@prefix biolink: .
@prefix infores: .
@prefix np: .
@prefix npx: .
@prefix orcid: .
@prefix pav: .
@prefix prov: .
@prefix rdf: .
@prefix rdfs: .
@prefix sub: .
@prefix this: .
@prefix xsd: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo .
}
sub:assertion {
a biolink:ChemicalEntity;
rdfs:label "Quazepam";
biolink:category biolink:ChemicalEntity .
a biolink:DiseaseOrPhenotypicFeature;
rdfs:label "insomnia";
biolink:category biolink:DiseaseOrPhenotypicFeature .
sub:_1 a biolink:Association;
rdf:object ;
rdf:predicate biolink:treats;
rdf:subject ;
biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
biolink:category biolink:Association;
biolink:publications .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2022-10-24T09:02:36.234884"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-1501-1082;
prov:wasQuotedFrom "Quazepam is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings." .
biolink: pav:version "2.3.0" .
}
sub:pubinfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB";
npx:hasSignature "W0yQA/4yo0tqg08MddmOcOmUPKUBfNkBUaBV5LCcET16hf0YiJFm+qq2jelP3bwY9lUkglVLTKI7KiMUrxDSap8rRMANb8D/7dU6FpqE/Tc3NLzZhlR+WguADJRxJ9JAvxD3RiSnVVihTdGMp+qSKlLmHNZur9liCccB/gqUk04=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2022-10-24T09:02:36.234884"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-1501-1082 .
}